MediPharm Labs Corp. LABS MEDIF, a pharmaceutical company specialized in cannabis, has announced that McMaster University, a partner of the company, has been given permission by Health Canada to conduct a clinical trial using some of MediPharm’s cannabinoid formulations.
MediPharm called the decision “a key milestone in moving forward with the Company’s strategy to be the go-to cannabis partner for pharmaceuticals containing cannabis.”
A phase 2, double-blind, randomized, placebo-controlled trial will evaluate the efficacy and safety of cannabis oil for the treatment of insomnia in major depressive disorder.
The study is being conducted by a clinical research group led by Dr. Benicio Frey, professor at McMaster University and psychiatrist at St. Joseph’s Healthcare Hamilton.
The MediPharm formulations to be tested include a CBD product called CBD50 and a CBD/THC product called CBD10:2.
MediPharm Labs will use its Cannabis Drug Licence and Drug Establishment Licence to provide access to clinical trial material for the study.
“As a pharmaceutical company specialized in cannabis, MediPharm Labs is encouraged by the ongoing research and development of drugs containing cannabis," said Keith Strachan, president and interim CEO of MediPharm Labs. "This study will create opportunities to show efficacy in our already commercialized cannabis oil while also making progress on our long-term goal to manufacture pharmaceutical drugs containing cannabinoids as an active ingredient.”
In June 2021, the university received permission to use CBD50 for a randomized trial studying the effect of CBD against placebo on persistent post-surgical pain following total knee arthroplasty.
Photo by Lux Graves on Unsplash
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.